1. Kyle RA, Rajkumar SV. Multiple Myeloma. N Engl J Med 2004; 351: 1860

2. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412-20.

3. He Y, wheatley K, Clark O, et al. Early versus deferred treatment for early stage multiple myeloma. Cochrane Database Syst Rev 2003.

4. Hjorth M, Hellquist L, Holmberg E, et al. Initial versus deferred melphalan-predisone therapy for asymptomatic multiple myeloma stage I a randomized study. Myeloma Group of Western Sweden. Eur J Haematol 1993; 50: 95-102.

5. Durie BG, Stock-Novack D, Salmon SE, et al. Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study. Blood 1990; 75: 823-30.

6. Michalaki VJ, Hall J, Henk JM, et al. Definitive radiotherapy for extramedullary plasmocytomas of the head and neck. Br J Radiol 2003; 76: 738-41.

<< volver